GB1554901A - Process for the manufacutre of -20 - ketosteroids - Google Patents

Process for the manufacutre of -20 - ketosteroids

Info

Publication number
GB1554901A
GB1554901A GB23849/76A GB2384976A GB1554901A GB 1554901 A GB1554901 A GB 1554901A GB 23849/76 A GB23849/76 A GB 23849/76A GB 2384976 A GB2384976 A GB 2384976A GB 1554901 A GB1554901 A GB 1554901A
Authority
GB
United Kingdom
Prior art keywords
manufacutre
ketosteroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB23849/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of GB1554901A publication Critical patent/GB1554901A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
GB23849/76A 1975-06-11 1976-06-09 Process for the manufacutre of -20 - ketosteroids Expired GB1554901A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2526373A DE2526373C2 (de) 1975-06-11 1975-06-11 Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑-5α-20-Ketosteroiden

Publications (1)

Publication Number Publication Date
GB1554901A true GB1554901A (en) 1979-10-31

Family

ID=5948981

Family Applications (1)

Application Number Title Priority Date Filing Date
GB23849/76A Expired GB1554901A (en) 1975-06-11 1976-06-09 Process for the manufacutre of -20 - ketosteroids

Country Status (10)

Country Link
US (1) US4061661A (https=)
JP (1) JPS51149260A (https=)
CH (1) CH620452A5 (https=)
DD (1) DD125699A5 (https=)
DE (1) DE2526373C2 (https=)
DK (1) DK137837C (https=)
FR (1) FR2314197A1 (https=)
GB (1) GB1554901A (https=)
HU (1) HU174227B (https=)
NL (1) NL7606137A (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748442C3 (de) * 1977-10-26 1981-08-27 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17α-(3-Jodbenzoyloxy)-9α -chlor4-pregnen-3.20-dione, Zwischenprodukte und Verfahren zu ihrer Herstellung, 9α -chlor-17α, 21-dihydroxy-1,4-pregnadien-3,20-dion und dieses enthaltende Arzneimittel
US4252729A (en) * 1978-05-12 1981-02-24 Hoffmann-La Roche Inc. Steroids and process for their manufacture
US4252719A (en) * 1978-08-17 1981-02-24 Research Corporation Steroid conversion method and products produced thereby
DE2929558C2 (de) * 1979-07-18 1982-03-11 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑ und/oder Δ↑1↑↑6↑ ungesättigten Steroiden
US4328162A (en) * 1980-09-05 1982-05-04 Eastman Kodak Company Process for preparing 9,11-unsaturated steroidal compound from the corresponding saturated steroidal compound
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
CN119192266A (zh) 2011-10-14 2024-12-27 萨奇治疗股份有限公司 3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
JP6470258B2 (ja) 2013-04-17 2019-02-13 セージ セラピューティクス， インコーポレイテッド １９−ノルｃ３，３−ジ置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法
ES2807264T3 (es) 2013-04-17 2021-02-22 Sage Therapeutics Inc Esteroides neuroactivos 19-nor para métodos de tratamiento
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
WO2015010054A2 (en) 2013-07-19 2015-01-22 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
ES2848823T3 (es) 2013-08-23 2021-08-12 Sage Therapeutics Inc Esteroides neuroactivos, composiciones y usos de los mismos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10577390B2 (en) 2014-10-16 2020-03-03 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
ME03809B (me) 2014-10-16 2021-04-20 Sage Therapeutics Inc KOMPOZICIJE I POSTUPCI ZA LEČENJE POREMEĆAJA CNS-a
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
WO2016123056A1 (en) 2015-01-26 2016-08-04 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP4155314A1 (en) 2015-02-20 2023-03-29 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US20180311258A1 (en) * 2015-04-10 2018-11-01 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
US20190233465A1 (en) 2016-07-11 2019-08-01 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
CA3116892A1 (en) * 2018-10-19 2020-04-23 Sage Therapeutics, Inc. 9(11)-unsaturated neuroactive steroids and their methods of use
EP3712161A1 (en) 2019-03-19 2020-09-23 Bionice, S.L.U. Process for preparing high puritiy allopregnanolone and intermediates thereof
CR20240234A (es) 2019-05-31 2024-07-09 Sage Therapeutics Inc ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2681353A (en) * 1952-03-11 1954-06-15 Sterling Drug Inc Chlorination of keto-steroids
GB1380248A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy steroids and esters thereof

Also Published As

Publication number Publication date
DE2526373A1 (de) 1976-12-30
DE2526373C2 (de) 1983-11-10
JPS6146480B2 (https=) 1986-10-14
NL7606137A (nl) 1976-12-14
FR2314197A1 (fr) 1977-01-07
CH620452A5 (https=) 1980-11-28
US4061661A (en) 1977-12-06
DD125699A5 (https=) 1977-05-11
DK137837B (da) 1978-05-16
FR2314197B1 (https=) 1981-03-20
JPS51149260A (en) 1976-12-22
HU174227B (hu) 1979-11-28
DK260976A (da) 1976-12-12
DK137837C (da) 1978-10-23

Similar Documents

Publication Publication Date Title
YU262076A (en) Process for obtaining 2-phenyl-3-aroylbenzothiophene
GB1554901A (en) Process for the manufacutre of -20 - ketosteroids
YU39342B (en) Process for obtaining 1,2,3-thiadiazolyl-carbamides
ZM7076A1 (en) Process
JPS5233629A (en) Process for manufacturing alkyloxysilane
YU100676A (en) Process for obtaining piperazinylpyrazine
YU147976A (en) Process for obtaining 11-deoxy-16-aryloxy-omega-tetranoprostaglandin
GB1554153A (en) Process for making 2-amino-2-alkylthionitroethylenes
YU233676A (en) Process for obtaining new n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
GB1543260A (en) Continuous process for aminoazobenzenes
JPS5251321A (en) Process for manufacturing 44alkyllthiosemicarbazides
YU196776A (en) Process for obtaining phosphor-dichlorido-thiolate
PT65369A (en) Reduction process
YU94182A (en) Process for obtaining 6-alkoxy-alpha-carboxy-penicillin
YU262276A (en) Process for obtaining aroyl-phenyl naphthalines
JPS5211137A (en) Process for providing members having selffcleaning property
JPS5251322A (en) Process for manufacturing ssalkylphosphorodihalogenidedithioate
HU172553B (hu) Sposob poluchenija proizvodnykh -3-aciloksimetil-cefem- ili -3-tiometil-cefem- soedinenijj
GB1549646A (en) Gelatin-hardening process
YU40278B (en) Process for obtaining n-alkenyl-2-amino-pyrrolidine
ZM10076A1 (en) Reduction process
JPS5281579A (en) Crossslinking process
AU1297176A (en) Cold-grinding process
YU160476A (en) Process for obtaining gamma-pyrone
IL50143A0 (en) Process for manufacturing chlorothianthrenes

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee